Tentative USFDA nod for Matrix’s HIV drug

Tentative USFDA nod for Matrix’s HIV drug
Comment E-mail Print Share
First Published: Fri, Mar 13 2009. 10 19 PM IST
Updated: Fri, Mar 13 2009. 10 19 PM IST
Mumbai:Matrix Laboratories Ltd said late Thursday it got a tentative approval for its antiretroviral tablets from the US Food and Drug Administration (USFDA).
The drug maker has received the tentative approval for abbreviated new drug application for Lopinavir or Ritonavir tablets of 200-50 mg dosages, it said in a statement.
Comment E-mail Print Share
First Published: Fri, Mar 13 2009. 10 19 PM IST